There are over 160 proteins that misfold and cause disease in the body, including in many rare indications as well as in major diseases (cancer, diabetes). The Treventis team is exploring the use of CCM for designing drugs in these indications and welcomes inquiries for specific collaborations or partnerships in protein misfolding disorders. Please contact us for more information.
Treventis recognizes collaboration and support from the following organizations:

Wellcome

CHUM

Washington University in St. Louis

UHN

York University

St. Michael

Ontario Centres of Excellence

University of Toronto

Atlantic Canada Opportunities Agency

BioAdvance

Columbia University

cqdm